Use of immobilized artificial membrane chromatography for drug transport applications

Journal of Pharmaceutical Sciences

Volumn 87, Issue 12, 1998, Pages 1471-1478

  Stewart, Barbra H ^a   Chan, Helen ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEPHALOSPORIN DERIVATIVE; HUMAN GROWTH HORMONE; LIPOSOME; PHENOTHIAZINE DERIVATIVE; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROTEINASE INHIBITOR; TRIAZINE DERIVATIVE;

ARTIFICIAL MEMBRANE; BLOOD BRAIN BARRIER; CHROMATOGRAPHY; DRUG ABSORPTION; DRUG TRANSPORT; HUMAN; LIPOPHILICITY; MEMBRANE PERMEABILITY; MICHAELIS CONSTANT; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTITION COEFFICIENT; SHORT SURVEY;

EID: 0031774541     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980262n     Document Type: Short Survey

References (53)

1. Schanker, L. S.; Tocco, D. J.; Brodie, B. B.; Hogben, C. A. M. Absorption of Drugs from the Rat Small Intestine. J. Pharmacol. Exp. Ther. 1958, 123, 81-88.
2. Houston, J. B.; Upshall, D. G.; Bridges, J. W. A Réévaluation of the Importance of Partition Coefficients in the Gastrointestinal Absorption of Nutrients. J. Pharmacol. Exp. Ther. 1974, 189, 244-254.
3. Dressman, J. B.; Amidon, G. L.; Fleisher, D. Absorption Potential: Estimating the Fraction Absorbed for Orally Administered Compounds. J. Pharm. Sei. 1985, 74, 588-589.
4. Banks, W. A.; Kastin, A. J. Peptides and the Blood-Brain Barrier: Lipophilicity as a Predictor of Permeability. Brain Res. Bull. 1985, 15, 287-292.
5. Levin, V. A. Relationship of Octanol/Water Partition Coefficient and Molecular Weight to Rat Brain Capillary Permeability. J. Med. Chem. 1980, 23, 682-684.
6. Rim, S.; Audus, K. L.; Borchardt, R. T. Relationship of Octanol/Buffer and Octanol/Water Partition Coefficients to Transcellular Diffusion Across Brain Microvessel Endothelial Cell Monolayers. Int. J. Pharm. 1986, 32, 79-84.
7. Smith, R. N.; Mansch, C.; Ames, M. M. Selection of a Reference Partitioning System for Drug Design Work. J. Pharm. Sei. 1975, 64, 599-606.
8. He, Y.-L.; Murby, S.; Warhurst, G.; Gifford, L.; Walker, D.; Ayrton, J.; Eastmond, R., Rowland, M. Species Differences in Size Discrimination in the Paracellular Pathway Reflected by Oral Bioavailability of PolyCethylene glycol) and DPeptides. J. Pharm. Sei. 1998, 87, 626-633.
9. Madara, J. L.; Dharmsathaphorm, K. Occluding Junction Structure-Function Relationships in a Cultured Epithelial Monolayer. J. Cell Biol. 1985, 101, 2124-2133.
10. Lampidis, T. J.; Kolonias, D.; Podona, T.; Israel, M.; Safa, A. R.; Lothstein, L.; Savaraj, N.; Tapiero, H.; Preibe, W. Circumvention of P-GP MDR as a Function of Anthracycline Lipophilicity and Charge. Biochemistry 1997,36, 2679-2685.
11. Smith, Q. R.; Momma, S.; Aoyagi, M.; Rapoport, S. I. Kinetics of Neutral Amino Acid Transport Across the Blood-Brain Barrier. J. Neurochem. 1987, 49, 1651-1658.
12. Ho, N. F. H.; Park, J. Y.; Morozowich, W.; Higuchi, W. I. Physical Model Approach to the Design of Drugs with Improved Intestinal Absorption. In Design of Biopharmaceutical Properties through Prodrugs and Analogues', Roche, E. B., Ed.; APhA/APS: Washington, D.C., 1977; pp 136-277.
13. van de Waterbeemd, H.; Mannhold, R. Lipophilicity Descriptors for Structure-Property Correlation Studies: Overview of Experimental and Theoretical Methods and A Benchmark of log P Calculations. In Lipophilicity in Drug Action and Toxicology; Vol. 4 of Methods and Principles in Medicinal Chemistry; Pliska, V., Testa, B., van de Waterbeemd, H., Eds; VCH Publishers: New York, 1996; pp 402-418.
14. Leo, A. J. Hydrophobie Parameter: Measurement and Calculation. In Molecular Design and Modeling: Concepts and Applications; Vol. 202A of Methods in Enzymology, Part A, Proteins, Peptides and Enzymes; Langone, J. J., Ed.; Academic Press: New York, 1991; pp 544-591.
15. Stewart, B. H.; Chan, O. H.; Jezyk, N.; Fleisher, D. Discrimination Between Drug Candidates Using Models for Evaluation of Intestinal Absorption. Adv. Drug Del. Rev. 1997,23, 27-45.
16. Clarke, F. H.; Cahoon, N. M. Potentiometric Determination of the Partition and Distribution Coefficients of Dianionic Compounds. J. Pharm. Sei. 1995, 84, 53-54.
17. Avdeef, A. Assessment of Distribution-pH Profiles. In Lipophilicity in Drug Action and Toxicology; Vol. 4 of Methods and Principles in Medicinal Chemistry; Pliaka, V., Testa, B., van de Waterbeemd, H., Eds.; VCH Publishers: New York, 1996; pp 109-139.
18. Dorsey, J. G.; Khaledi, M. G. Hydrophobicity Estimations by Reversed-phased Liquid Chromatography. J. Chromatogr. A 1993, 656, 485-499.
19. Lambert, W. J. Modeling Oil-Water Partitioning and Membrane Permeation Using Reversed-Phased Liquid Chromatography. J. Chromatogr. A 1993, 656, 469-484.
20. Beigi, F.; Yang, Q.; Lundahl, P. Immobilized-Liposome Chromatographie Analysis of Drug Partitioning into Lipid Bilayers. J. Chromatogr. A 1995, 704, 315-321.
21. Brekkan, E.; Lu, L.; Lundahl, P. Properties of ImmobilizedLiposome-Chromatographic Supports for Interaction Analysis. J. Chromatogr. A 1995, 711, 33-42.
22. Lundahl, P.; Beigi, F. Immobilized Liposome Chromatography of Drugs for Model Analysis of Drug-Membrane Interactions. Adv. Drug Del. Rev. 1997, 23, 221-227.
23. Pidgeon, C.; Venkataram, U. V. Immobilized Artificial Membrane Chromatography: Supports Composed of Membrane Lipids. Anal. Kochern. 1989, 176, 36-47.
24. Ong, S.; Liu, H.; Qiu, X.; Bhat, G.; Pidgeon, C. Membrane Partition Coefficients Chromatographically Measured Using Immobilized Artificial Membrane Surfaces. Anal. Chem. 1995, 67, 755-762.
25. Ong, S.; Cai, S. J.; Bernai C.; Rhee, D.; Qui, X.; Pidgeon, C. Phospholipid Immobilization on Solid Surfaces. Anal. Chem. 1994, 66, 782-792.
26. Pidgeon, C.; Ong, S.; Choi, H.; Liu, H. Preparation of Mixed Ligand Immobilized Artificial Membranes for Predicting Drug Binding to Membranes. Anal. Chem. 1994, 66, 2701-2709.
27. Radwanska, A.; Frackowiak, T.; Ibrahim, H.; Aubry, A.-F.; Kaliszan, R. Chromatographie Modelling of Interactions Between Melanin and Phenothiazine and Dibenzazepine Drugs. Biomed. Chromatogr. 1995, 9, 233-237.
28. Kaliszan, R.; Nasal, A.; Turowski, M. Quantitative StructureRetention Relationships in the Examination of the Topography of the Binding Site of Antihistamine Drugs on ai-Acid Glycoprotein. J. Chromatogr. A 1996, 722, 25-32.
29. Kaliszan, R.; Kaliszan, A.; Wainer, I. W. Deactivated Hydrocarbonaceous Silica and Immobilized Artificial Membrane Stationary Phases in High-Performance Liquid Chromatographie Determination of Hydrophobicities of Organic Bases: Relationship to log P and CLOGP. J. Pharm. Biomed. Anal. 1993, 11, 505-511.
30. Beigi, F.; Gottschalk, L; Hagglund, C. L.; Haneskog, L.; Brekkan, E.; Zhang, Y.; Osterberg, T.; Lundahl, P. Immobilized Liposome and Biomembrane Partitioning Chromatography of Drugs for Prediction of Drug Transport. Int. J. Pharm. 1998, 164, 129-137.
31. Conradi, R. A.; Burton, P. S.; Borchardt, R. T. Physicochemical and Biological Factors that Influence a Drug-s Cellular Permeability by Passive Diffusion. In Lipophilicity in Drug Action and Toxicology; Vol. 4 of Methods and Principles in Medicinal Chemistry; Pliska, V., Testa, B., van de Waterbeemd, H., Eds.; VCH Publishers: New York, 1996; pp 233252.
32. Yang, C. Y.; Cai, S. J.; Liu, H.; Pidgeon, C. Immobilized Artificial Membranes - Screens for Drug Membrane Interactions. Adv. Drug Del. Rev. 1997, 23, 229-256.
33. Turowski, M.; Kaliszan, R. Keratin Immobilized on Silica as a New Stationary Phase for Chromatographie Modelling of Skin Permeation. J. Pharm. Biomed. Anal. 1997,15, 13251333.
34. Kararli, T. T. Comparison of the Gastrointestinal Anatomy, Physiology, and Biochemistry of Humans and Commonly Used Laboratory Animals. Biopharm. Drug Dispos. 1995,16, 351-380.
35. Markovich, R. J.; Stevens, J. M.; Pidgeon, C. Fourier Transform Infrared Assay of Membrane Lipids Immobilized to Silica: Leaching and Stability of Immobilized Artificial Membrane-Bonded Phases. Anal. Biochem. 1989,182, 237244.
36. Markovich, R. J.; Qui, X. X.; Nichols, D. E.; Pidgeon, C.; Invergo, B.; and Alvarez, F. M. Silica Subsurface Amine Effect on the Chemical Stability and Chromatographie Properties of End-capped Immobilized Artificial Membrane Surfaces. Anal. Chem. 1991,63, 1851-1860.
37. Liu, H. L; Ong, S. W.; Glunz, L.; Pidgeon, C. Predicting Drug Membrane Interactions by HPLC Structural Requirements of Chromatographie Surfaces. Anal. Chem. 1995, 67, 35503557.
38. Ong, S.; Pidgeon, C. Thermodynamics of Solute Partitioning into Immobilized Artificial Membranes. Anal. Chem. 1995, 67, 2119-2228.
39. Pidgeon, C.; Ong, S.; Liu, H.; Qiu, X.; Pidgeon, M.; Dantzig, A. H.; Munroe, J.; Hornback, W. J.; Kasher, J. S.; Glunz, L.; Szczerba, T. IAM Chromatography: An In Vitro Screen for Predicting Drug Membrane Permeability. J. Med. Chem. 1995, 38, 590-594.
40. Kaliszan, R.; Nasal, A.; Bucinski, A. Chromatographie Hydrophobicity Parameter Determined on an Immobilized Artificial Membrane Column: Relationships to Standard Measures of Hydrophobicity and Bioactivity. Ear. J. Med. Chem. 1994, 29, 163-170.
41. Barbato, F.; La Rotonda, M. L; Quaglia, F. Chromatographie Indexes on Immobilized Artificial Membranes for Local Anesthetics: Relationships with Activity Data on Closed Sodium Channels. Pharm. Res. 1997, 14, 1699-1705.
42. Barbato, F.; La Rotonda, M. L; Quaglia, R. Interactions of Nonsterpidal Antiinflammatory Drugs with Phospholipids: Comparison between Octanol/Buffer Partition Coefficients and Chromatographie Indexes on Immobilized Artificial Membranes. J. Pharm. Sei. 1997, 86, 225-229.
43. Barbato, F.; La Rotonda, M. L; Quaglia, F. Chromatographie Indices Determined on an Immobilized Artificial Membrane (IAM) Column as Descriptors of Lipophilic and Polar Interactions of 4-Phenyldihydropyridine Calcium-Channel Blockers with Biomembranes. Eur. J. Med. Chem. 1996,31, 311318.
44. Pauletti, G. M.; Gangwar, S.; Okumu, F. W.; Siahaan, T. J.; Stella, V. J.; Borchardt, R. T. Esterase-Sensitive Cyclic Prodrugs of Peptides: Evaluation of an Acyloxyalkoxy Promoiety in a Model Hexapeptide. Pharm. Res. 1996,13,16151623.
45. Pauletti, G. M.; Okumu, F. W.; Borchardt, R. T. Effect of Size and Charge on the Passive Diffusion of Peptides Across Caco-2 Cell Monolayers via the Paracellular Pathway. Pharm. Res. 1997, 14, 164-168.
46. Okumu, F. W.; Pauletti, G. M.; Vander Velde, D. G.; Siahaan, T. J.; Borchardt, R. T. Effect of Restricted Confprmational Flexibility on the Permeation of Model Hexapeptides Across Caco-2 Cell Monolayers. Pharm. Res. 1997, 14, 169-175.
47. Barton, P.; Davis, A. M.; McCarthy, D. J.; Webborn, P. J. H. Drug-Phospholipid Interactions. 2. Predicting the Sites of Drug Distribution Using rc-Octanol/Water and Membrane/ Water Distribution Coefficients. J. Pharm. Sei. 1997, 86, 1034-1039.
48. Stewart, B. H.; Chung, F. Y.; Tait, B.; Blankley, C. J.; Chan, O. H. Hydrophobicity of HIV Protease Inhibitors by Immobilized Artificial Membrane Chromatography: Application and Significance to Drug Transport. Pharm. Res. 1998, 15, 1401-1406.
49. Marcello, J.; Eddy, E. P.; Smith, P. L.; Chêne, H. Y.; Mitchell, R. C.; Lee, C.-P. Evaluation of Immobilized Artificial Membrane Technology to Predict Blood Brain Barrier Permeability. Abstracts of Papers, National Meeting of the American Chemical Society, New Orleans, LA, 1996.
50. Salminen, T.; Pulli, A.; Taskinen, J. Relationship Between Immobilised Artificial Membrane Chromatographie Retention and the Brain Penetration of Structurally Diverse Drugs. J. Pharm. Biomed. Anal. 1997, 15, 469-477.
51. Ducarme, A.; Neuwels, M.; Goldstein, S.; Massingham, R. IAM Retention and Blood Brain Barrier Penetration. Eur. J. Med. Chem. 1998, 33, 215-223.
52. Leone-Bay, A.; Ho, K.-K.; Agarwal, R.; Baughman, R. A.; Chaudhard, K.; DeMorin, F.; Genoble, L.; Mclnnes, C.; Lercara, C.; Milstein, S.; O'Toole, D.; Sarubbi, D.; Variano, B.; Paton, D. R. 4-[4-[(2-Hydroxybenzoyl)amino]phenyl] butyric Acid as a Novel Oral Delivery Agent for Recombinant Human Growth Hormone. J. Med. Chem. 1996, 39, 2571 2578.
53. Pidgeon, C.; Hauer, K. L.; Liu, H. L.; Yin, J. The role of Membrane Binding constants in Drug Discovery. AAPS Symposia Abstracts and Biographies, Plenum Press: Boston, 1997; p 41.